Abstract CT302: The safety, tolerability, and efficacy of HS-10504 in patients with EGFR mutation-positive locally advanced or metastatic NSCLC: Initial results from a first-in-human phase 1 study
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: First Affiliated Hospital of Guangzhou Medical University, Zhengzhou University, Henan Cancer Hospital, Hunan Cancer Hospital, Sichuan Cancer Hospital, Shandong First Medical University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Peking University Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Fujian Provincial Cancer Hospital, China Medical University, Guangdong Provincial Hospital of Chinese Medicine, First Affiliated Hospital of Wenzhou Medical University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154707151